SB 883
Referred
Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.
- Texas
- Senate
- Introduced Jan 23, 2025
- Session 89R
Official Bill Page
Loading official bill page…
This state’s bills aren’t available here
Texas’s legislature doesn’t allow its bill pages to be shown on other sites. You can read the full bill on the official page.
View on official siteLegislative Timeline
28 actions-
Referred to Public Health
-
Read first time
-
Received from the Senate
-
Reported engrossed
-
Record vote
-
Passed
-
Read 3rd time
-
Record vote
-
Rules suspended-Regular order of business
-
Record vote
-
Read 2nd time & passed to engrossment
-
Record vote
-
Rules suspended-Regular order of business
-
Co-author authorized
-
Placed on intent calendar
-
Committee report printed and distributed
-
Reported favorably w/o amendments
-
Vote taken in committee
-
Considered in public hearing
-
Left pending in committee
-
Testimony taken in committee
-
Considered in public hearing
-
Scheduled for public hearing on . . .
-
Co-author authorized
-
Referred to Health & Human Services
-
Read first time
-
Filed
-
Received by the Secretary of the Senate